Neuland Laboratories Limited — Financials & Forensics
Sector: Healthcare · NSE: NEULANDLAB · BSE: 524558 · ISIN: INE794A01010
18 Aug 2026
Add NEULANDLAB to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹951 Cr | ₹1,191 Cr | ₹1,559 Cr | ₹1,477 Cr | ₹2,023 Cr |
| EBITDA | ₹143 Cr | ₹272 Cr | ₹463 Cr | ₹323 Cr | ₹574 Cr |
| EBITDA margin | 15.0% | 22.8% | 29.7% | 21.9% | 28.4% |
| Profit after tax | ₹64 Cr | ₹164 Cr | ₹300 Cr | ₹260 Cr | ₹364 Cr |
Deeper analysis
Recent filings by Neuland Laboratories Limited
-
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of
17 Aug 2026 · Insider Trading
-
Intimation regarding completion of US FDA Inspection
14 Aug 2026 · Regulatory Compliance
-
Transcript of the Earnings Call conducted on August 5, 2026
10 Aug 2026 · Financial Results
-
Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026
07 Aug 2026 · General Update
-
Copy of Newspaper Publication
06 Aug 2026 · Regulatory Compliance
Never miss a filing again
About Neuland Laboratories Limited on Indian Stock Alerts
Indian Stock Alerts tracks Neuland Laboratories Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.